Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
– Sell
-2,900
Closed -$887K – 3159
2014
Q1
$887K Buy
+2,900
New +$921K ﹤0.01% 1229

Other funds holding BIIB

BlackRock's BIIB Position: Q3 2026 in Review

BlackRock increased its Biogen (BIIB) stake by 0.65% in Q3 2026, buying an estimated $21.9M and bringing the position to 16,089,189 shares worth $3.63B. The position accounts for 0.05% of the portfolio, ranked #278.

BlackRock first reported a position in BIIB in Q2 2013 and has held it in 54 quarters since. The position peaked at $5.83B in Q3 2018. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • BlackRock held 16,089,189 shares of Biogen worth $3.63B as of Q3 2026.
  • BlackRock bought 103,453 Biogen shares in Q3 2026, an estimated $21.9M.
  • Biogen made up 0.05% of BlackRock's portfolio in Q3 2026, its #278 holding.
  • BlackRock first reported a position in Biogen in Q2 2013 and has held it in 54 quarters since.
  • BlackRock's Biogen position peaked at $5.83B in Q3 2018.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.